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Introduction  
Accidents and injuries as major public 
health challenges of the new century. These 
injuries are always a significant cause of                                             
death and its complications. The importance 
of these kinds of injuries increases with the 
progression of the technology. Accidents 
A B S T R A C T  
The car accident is causes of 16000 deaths in a day. Central nerves system 
injury is one of the most important causes of morbidity and mortality. After 
head trauma neuron cell may be has dysfunction but the recovery is 
possible yet.  This recovery needs to suit cares. This study attempts for 
confirmation of efficacy of Sulfate Magnesium in moderate and sever head 
trauma. This study is a pilot study and clinical trial in 201 until 2011. The 
patients divided to two groups. First; sever head trauma (GCS <=8), second; 
moderate head trauma (8<=GCS<=12). Intervention group in both of 
groups was injected 250 micromole/kg sulfate magnesium besides 
definitive cares and witnessed group only have taken definitive cares. The 
study suggested in moderate and severe head trauma neurologic and 
radiologic outcome more acceptable in intervention group after injection 
sulfate magnesium. 
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and injuries accounts for the 205 of all 
disabilities (1). The importance of this topic 
is very significant in our country due to the 
high percent of the young and active 
population. Following to the accident, the 
injuries of the central nervous system is the 
main cause of the mortality and morbidity. 
The brain is at a high risk for injuries 
following the head traumas and this is the 
key factor of final outcome(2).   
The activity of the neurons, glial cells and 
endothelial cells faces with impairment 
following to the focal injuries. But this 
injury can be reversed in favorable 
conditions; these cells can recover over 
time. However, if events such as 
hypotension, increased intracranial pressure 
and hypoxemia are leaved untreated these 
cells will be lost. In these patients, we can 
help the recovery of the damaged cells with 
maintaining the perfusion of the brain cells, 
controlling of the intracranial pressure and 
preventing the secondary traumas(3-4).  
Although the improvement in the primary 
resuscitation and early diagnosis and surgery 
is at a fixed ration, but the improvement in 
the primary health cares improved the 
outcome significantly (5-6). Now, control of 
the CBF (cerebral blood flow) and 
metabolism in prevention and treatment of 
ischemia associated with pharmacological 
neuroprotective treatments get the best hope 
for improving the outcome of these patients 
(7).   
Since the trauma is the most common cause 
of the mortality in patients under the 45 
years and the brain injuries is the most 
important predictor of the outcome in 
traumatic patients. So any activity which can 
improve the brain activity can increase the 
quality of life in these kinds of patients (3-
4).  
Nowadays most of the researches is about 
the molecular and biochemical mechanisms 
of neural responses to the trauma and the 
cell recovery, findings of these researches 
have made the neurosurgeons to believe that 
the post traumatic first levels is vital and the 
success of upcoming treatments are related 
to adequate care at this phase. Excitatory 
receptors and their activity following the 
trauma and their role in cell death is of the 
related study topics (8-9)   
It is now proven that the severe stimulation 
of these receptors following the trauma can 
facilitate the cell death so the inactive cells 
in viable situation developed to death. The 
stimulation of these receptors can start some 
mechanisms that lead to cell death. If we can 
prevent or block their stimulation, the cell 
death rate can be decreased significantly and 
increase the possibility of the recovery.  
Magnesium can prevent the cell death and 
increase the cell recovery. This issue is now 
proven in animal studies and its accuracy is 
under experience in human beings.  Since 
the traumatic patients is one of the major 
problems of health care system in our 
country, like all other countries-and with 
regard to statistical reports which shows the 
Iran on top of the countries with traffic 
accidents mortalities in 2006, the importance 
of studies related to 1st, second and third 
degree of prevention is understood. With 
regard to the number of attending patients in 
Emam Reza Hospitals, we conducted the 
present study and the results are as below.  
Methods and Materials  
In a clinical trial study in Emergency 
Department of Tabriz University of Medical 
Sciences on patients with GCS 12, we 
evaluated the efficacy of Magnesium sulfate 
on prognosis of patients
 230
We randomly enrolled all the patients with 
GCS 12 who referred to emergency 
department in the first 12 hours of the 
trauma. The patients with brain death and 
patients who did not refer for further follows 
were excluded from the study. Patients was 
divided into two groups with severe head 
trauma and mild head trauma (GCS<8 and 
9<GCS<12 respectively). Forty patients 
were studied in every group and 50% of 
patients underwent Magnesium sulfate 
administration 250 micro moll/kg
 
Patients was examined primarily in 
emergency department and the in 
neurosurgery ward. The examiner physician 
was blinded for patients groups
From the point of ethical considerations, it 
was not possible to get consent from the 
patients because of low GCS levels of 
patients, and since most patients was 
attended to emergency department solely or 
with no identification documents. Based on 
the data of previous studies, this dose of 
Magnesium sulfate is completely safe which 
means this dose of Mg Sulfate produces 1.8 
micromole/liter serum levels, while the 
toxicity of Mg sulfate is produced in 2-4 
micromole/Liter doses which causes 
paresthesia and nausea
The injection is slow and once, so there no 
risk for the patients and consents was 
cancelled.  
Problems and Limitations: Reducing the 
number of cases in follow up period was of 
the major problems
Statistical Analysis  
The collected data were analyzed by SPSS-
17 statistical software. The collected data 
were expressed as percentage and mean ± 
SD. Continuous (quantitative) variables 
were compared by Independent samples and 
Paired t test. Categorical (qualitative) 
variables were compared by contingency 
tables and Chi-square test or Fisher's exact 
test. P-value 0.05 was considered 
statistically significant.  
Result and Discussion  
Evaluation of age and sex in patients of two 
groups was shown in table I. Improvement 
of at least 2 points in GCS time and 
Normalized neurological symptoms in 
patients of two groups were shown in table 
II. Radiological state of patients in two 
groups was shown in table III.  Normalized 
Radiological states in patients of two groups 
were shown in table IV. Hospitalize duration 
in patients of two groups were shown in 
table V.  
From the point of age distribution, most of 
the patients were in the range of 15 years to 
50 years(65 %) which is matched with the 
age distribution in other studies, The head 
trauma was significantly higher in male 
patients(75 % male compared 25 % female). 
The indicator of recovery was the minimum 
2 points of increase in GCS and the recovery 
was better and faster in patients receiving 
Magnesium sulfate (P=0.037).  
In patients who underwent the 
administration of magnesium sulfate, the 
mean time of neurologic sings normalization 
in the first day and third day was 
significantly faster than patients in control 
group( P=0.005 and P=0.007 respectively), 
after the day 3 there is no significant 
difference in two groups.  
Therefore, we can conclude that the time 
required for normalization in case group is 
significantly lower compared to the time 
required for normalization of the symptoms 
in control group, but the conclusion will be 
more complete with more case numbers. 
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Table.I Evaluation of age and sex in patients of two groups  
Case Group Control Group 
Moderate Sever Moderate Sever 
<15 year 3(15%) 4(20%) 3(15%) 2(10%) 
15-50 year 13(65%) 12(60%) 13(65%) 14(70%) 
Age 
> 50 year 4(20%) 4(20%) 4(20%) 4(20%) 
Male 13(65%) 15(75%) 16(80%) 16(80%) Sex 
Female 7(35%) 5(25%) 4(20%) 4(20%) 
Table.II Improvement of at least 2 points in GCS time and Normalized neurological symptoms  
in patients of two groups  
Case Group Control Group 
Moderate Sever Moderate Sever P 
1 day later 19(95%) 15(75%) 14(70%) 1(5%) 
3 days later 1(5%) 5(25%) 6(30%) 6(30%) 
 7 day later 0(0%) 0(0%) 0(0%) 3(15%) 
1 month later 0(0%) 0(0%) 0(0%) 0(0%) 
Improvement 
of at least 2 
points in GCS 
Not improved 0(0%) 0(0%) 0(0%) 10(50%) 
0.037 
1 day later 6(30%) 0(0%) 0(0%) 0(0%) 
3 days later 13(65%) 1(5%) 10(50%) 0(0%) 
 7 day later 1(5%) 8(40%) 9(45%) 2(10%) 
1 month later 0(0%) 7(35%) 0(0%) 5(25%) 
Normalized 
neurological 
symptoms 
Death 0(0%) 4(20%) 1(5%) 13(65%) 
0.007 
Table.3 Radiological state of patients in two groups  
Case Group Control Group 
Moderate Sever Moderate Sever  
7 day 
later 
1 month 
later 
7 day 
later 
1 month 
later 
7 day 
later 
1 month 
later 
7 day 
later 
1 month 
later 
P 
Grade I 16(80%) 20(100%) 1(5%) 5(25%) 5(25%) 12(60%) 0(0%) 1(5%) 
Grade II 4(20%) 0(0%) 8(40%) 7(35%) 13(65%) 7(35%) 1(5%) 3(15%) 
Grade III 0(0%) 0(0%) 3(15%) 4(20%) 2(10%) 0(0%) 3(15%) 3(15%) 
Grade IV 0(0%) 0(0%) 8(40%) 0(0%) 0(0%) 0(0%) 16(80%) 0(0%) 
Death 0(0%) 0(0%) 0(0%) 4(20%) 0(0%) 1(5%) 0(0%) 13(65%) 
P<0.05 
 
Table.4 Normalized Radiological states in patients of two groups  
Case Group Control Group 
Moderate Sever Moderate Sever P 
1 day later 0(0%) 0(0%) 0(0%) 0(0%) 
3 days later 3(15%) 0(0%) 0(0%) 0(0%) 
 5 day later 11(55%) 1(5%) 6(30%) 0(0%) 
 7 day later 6(30%) 9(45%) 14(70%) 2(10%) 
1 month later 0(0%) 6(30%) 0(0%) 5(25%) 
P<0.05 
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Table.5 Hospitalize duration in patients of two groups  
Case Group Control Group 
Moderate Sever Moderate Sever P 
0-7 
day 
15(75%) 0(0%) 11(55%) 0(0%) 
8-14 
day 
5(25%) 3(15%) 6(30%) 3(15%) 
15-21 
day 
0(0%) 6(30%) 3(15%) 6(30%) 
22-28 
day 
0(0%) 3(15%) 0(0%) 3(15%) 
> 30 
day 
0(0%) 4(20%) 0(0%) 4(20%) 
0.07 
In patients with head trauma, the time of 
first neurologic recovery in the group 
receiving magnesium sulfate was 
significantly lower than the control group; 
this time was also significant in 1st, 3rd, 7th 
and 30th days after the trauma. The fast 
recovery time of neurologic signs can show 
the positive effect of magnesium sulfate in 
these patients.  
In the patients of case group, we observed 
the recovery of at least 2 GCSs but in the 
control group,505 of patients did not show 
any recovery.  
The comparison of two groups from the 
point of symptoms normalization was not 
different in 1st and 3rd days but the 
symptoms normalization was faster in 7th 
and 30 the days in case groups(P=0.033 and 
P=0.010 respectively).   
In patients with severe head trauma, the 
mortality rate was significantly lower in 
Magnesium sulfate group (P=0.010).  
The radiologic improvement rate after 1 day 
was significantly higher in magnesium 
sulfate group, 9 patients had radiologic 
improvement in case group while there were 
no cases of radiologic improvement in 
control group, this difference was 
statistically meaningful(P=0.0024) which 
indicates that Magnesium sulfate had 
improved the radiologic findings in 2 days 
of trauma.  
In patients with mild trauma, the radiologic 
improvement was significantly higher in 
Magnesium sulfate group until the day 5 
(P=0.026) this rate was equal in two groups 
in the upcoming days. This also indicates 
that Magnesium sulfate administration can 
cause the radiologic improvement to be 
faster while the neurologic effects 
improvement was faster than the radiologic 
effects.  
Radiologic normalization in two groups was 
not assessable until the day 5 but it was 
significantly higher in the magnesium 
sulfate group from the 7th day which shows 
that the radiologic improvement was better 
and more comparing to control group, This 
improvement is later in mild trauma group 
and can be due to the severity of the trauma 
which more time is needed for complete 
improvement.  
There was no significant difference in the 
outcome in mild head trauma patients, but 
the recovery was functionally faster in 
magnesium sulfate group.  
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In patients with severe head traumas, the 
outcome in 7th day was statistically better in 
Mg sulfate group (P=0.010) and Mg sulfate 
could improve the final recovery in the 7th 
day, the outcome was also better in the 30 
the day in the Mg sulfate group significantly 
(P=0.023).  
The mean time of hospitalization was 5.38 
±1.82 days in case group comparing with 
7.92 ± 2.32 days in control group, the 
difference between two group in 
hospitalization days was not 
significant(P=0.070). However, in the 
patients with severe head traumas, the mean 
time of hospitalization was significantly 
lower in Magnesium sulfate group. A motor 
vehicle accident was the major cause of 
head traumas in our study.  
Conclusion  
In the patients with mild head trauma, the 
radiologic and neurologic recovery was 
faster in intervention group comparing to 
control group but this few number of cases 
could not prove the improvement in 
hospitalization and outcome. However, the 
rate of recovery was significant and requires 
more studies. In the patients with severe 
head traumas, the MG sulfate administration 
can significantly cause the neurologic and 
radiologic recovery. Hospitalization period 
and outcome was better comparing to 
control group. Mg sulfate could reduce the 
mortality significantly in the intervention 
group. The cases was also few to generalize 
the results. So it is recommended to conduct 
other trials with more number of cases. 
However, it can be concluded that inject 
able Magnesium sulfate can improve the 
recovery time and outcome in patients with 
severe head trauma in the first 12 hours of 
trauma and reduce the mortality rate; this 
agent can make the recovery process faster 
in mild head traumatic patients. 
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